09.15.2016 Verily, Alphabet and Google Look to Cure Diabetes – With Nanobots? Another example where big tech and biology are blurring the lines. Sanofil is a target of Verily, an Alphabet Division (Google 2.0) – and they may have a nifty nanobot cure for diabetes. Read more
